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Abstract
Background: Loss-of-function mutations in PTEN-induced kinase 1 (PINK1) have been linked to familial Parkinson’s
disease, but the underlying pathogenic mechanism remains unclear. We previously reported that loss of PINK1
impairs mitochondrial respiratory activity in mouse brains.
Results: In this study, we investigate how loss of PINK1 impairs mitochondrial respiration using cultured primary
fibroblasts and neurons. We found that intact mitochondria in PINK1−/− cells recapitulate the respiratory defect in
isolated mitochondria from PINK1−/− mouse brains, suggesting that these PINK1−/− cells are a valid experimental
system to study the underlying mechanisms. Enzymatic activities of the electron transport system complexes are
normal in PINK1−/− cells, but mitochondrial transmembrane potential is reduced. Interestingly, the opening of the
mitochondrial permeability transition pore (mPTP) is increased in PINK1−/− cells, and this genotypic difference
between PINK1−/− and control cells is eliminated by agonists or inhibitors of the mPTP. Furthermore, inhibition of
mPTP opening rescues the defects in transmembrane potential and respiration in PINK1−/− cells. Consistent with
our earlier findings in mouse brains, mitochondrial morphology is similar between PINK1−/− and wild-type cells,
indicating that the observed mitochondrial functional defects are not due to morphological changes. Following
FCCP treatment, calcium increases in the cytosol are higher in PINK1−/− compared to wild-type cells, suggesting
that intra-mitochondrial calcium concentration is higher in the absence of PINK1.
Conclusions: Our findings show that loss of PINK1 causes selective increases in mPTP opening and mitochondrial
calcium, and that the excessive mPTP opening may underlie the mitochondrial functional defects observed in PINK1
−/− cells.
Keywords: Parkinson’s disease, Mitochondrial respiration, Mitochondrial transmembrane potential, Mitochondrial
permeability transition pore, Calcium
Introduction
Recessively inherited loss of function mutations in the
PINK1 gene have been linked to familial Parkinson’s dis-
ease (PD). The PINK1 protein bears a 34 amino acid
mitochondrial targeting domain [1] and has been shown
to localize within mitochondria [2]. Mitochondrial dys-
function has long been thought to play a key role in PD
pathogenesis, based in part on postmortem studies that
showed mitochondrial impairment (e.g. reduced complex
I activity) and oxidative damage in idiopathic PD brains
[3]. This is further supported by observations that mito-
chondrial complex I inhibitors, such as MPTP [4] and
rotenone [5] produce parkinsonian syndromes in
humans and experimental animal models.
Genetic studies in Drosophila showed that PINK1 is
involved in the maintenance of mitochondrial morph-
ology by interacting with components of the mitochon-
drial fission and fusion machinery [6-9]. Loss of PINK1
in Drosophila appears to promote mitochondrial fusion,
though the effects of PINK1 inactivation on mitochon-
drial morphology in cultured mammalian cells are less
consistent, ranging from promotion of mitochondrial
fragmentation or fusion to no effects [10-14]. Despite
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vation on mitochondrial morphology in mammalian cul-
ture systems, several functional defects have been
reported consistently, including impairment of mito-
chondrial respiration [15-20] and reduction of mito-
chondrial transmembrane potential [1,11,15,16,21]. Our
previous analysis of PINK1−/− mice led to the first re-
port showing that PINK1 is required for mitochondrial
respiratory function in vivo [18]. However the cause of
these functional defects remains to be elucidated.
To determine the pathogenic cascade of events in in-
tact mitochondria, we derived primary mouse embryonic
fibroblasts (MEFs) and cortical neuronal cultures from
our PINK1−/− mice. Similarly to what we previously
reported in isolated mitochondria from the brain, mito-
chondrial respiration is impaired in PINK1−/− cells.
While the enzymatic activity of each complex composing
the electron transport system is normal, mitochondrial
transmembrane potential (ΔΨm) is reduced in PINK1−/−
MEFs and neurons. Interestingly, the reduction of ΔΨm
in PINK1−/− cells is associated with increased opening
of the mitochondrial permeability transition pore
(mPTP). Inhibition of the mPTP reverses the
depolarization of the mitochondrial inner membrane
and respiration defects seen in PINK1−/− cells. We did
not find evidences of increased oxidative stress, a com-
mon inducer of mPTP opening. In addition, we found
no detectable changes in mitochondrial morphology in
PINK1−/− cells. Together our findings highlight a role
of PINK1 in the regulation of the mitochondrial perme-
ability transition pore and suggest that increased open-
ing of the pore in the absence of PINK1 may be
responsible for the reduced mitochondrial transmem-
brane potential and the reduced respiratory activities.
Materials and methods
Primary MEF and cortical cultures
Mouse embryonic fibroblasts (MEFs) were derived from
embryos at embryonic day 14.5. After removing the head
and the inner organs embryos were individually minced
with scissors, treated with trypsin (1%v/v) for twelve
minutes at 37°C and dispersed mechanically and plated
with MEF media (Dulbecco′s Modified Eagle Medium
(DMEM), 10% fetal bovine serum (FBS), penicillin/
streptomycin (Gibco, Life Technologies, Grand Island,
NY, USA)). After they reached ~100% confluency, cells
were frozen down in DMEM containing 10% DMSO
(Sigma, St Louis, MO, USA). The number of MEF sam-
ples used in each experiment is specified in the figure
legends and reflects the number of individual cultures
derived from individual embryos used to derive MEFs.
Primary cortical cultures were prepared and main-
tained as described previously [22]. Experiments were
performed at 14±1 days in vitro. Cortices from different
pups were not pooled, and the number of experiments
specified in the legend reflects the number of different
cultures derived from individual pups.
Mitochondrial respiration
Mitochondrial respiration was assayed as the O2 con-
sumption of cell suspension using a Clark electrode
(Rank Brothers Ltd, Cambridge, England). Cells were
resuspended to a final density of 2.10
6 cells/ml in respir-
ation buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM
NaH2PO4, 25 mM Tris, pH 7.4 at 25°C). Endogenous
respiration activity was measured after addition of glu-
cose (10 mM, Sigma). For complex driven respiration,
plasma membranes were permeabilized by addition of
digitonin at a final concentration of 0.01% (Sigma). Cells
were supplemented with substrates for either complex I
(10 mM glutamate/malate, Sigma), II (10 mM succinate,
Sigma) or III (1 mM TMPD/1 mM ascorbate, Sigma) to-
gether with adenosine diphosphate (ADP, 1 mM, Sigma)
to the recording chamber. State 3 respiration activity
was then measured. ADP independent respiration activ-
ity (State 4) was monitored after addition of oligomycin
(2 μM, Sigma).
Enzymatic activity of ETS complexes and ATP synthase
All assays were performed on mitochondria isolated
from MEFs according to a previously established method
[23]. For each complex 5 μg of mitochondrial proteins
and 100 μl of each assay buffer were used. Complex I
(NADH: ubiquinone oxidoreductase) buffer (35 mM
NaH2PO4 pH 7.2, 5 mM MgCl2, 0.25% BSA, 2 mM
KCN, 1 μM antimycin, 97.5 μM ubiquinone-1, 0.13 mM
NADH, Sigma). Only the rotenone sensitive activity was
monitored by following the oxidation of NADH at
340 nm (OD 6220 M
-1.cm
-1). Complex II (succinate de-
hydrogenase) buffer (25 mM KH2PO4, 5 mM MgCl2,p H
7.2, 20 mM succinate, 50 μM 2,6-dichlorophenolindo-
phenol (DCPIP), 0.25% BSA, 2 mM KCN, 1 μM antimy-
cin, Sigma). Enzymatic activity was monitored by the
reduction of DCPIP/PES at 600 nm (OD 19100 M
-1.cm
-
1) after addition of 65 μM ubiquinone 1. Complex III ac-
tivity (decylubiquinol/ferricytochrome C oxidoreductase)
buffer (3 mM sodium azide, 1.5 μM rotenone, 50 μM
ferricytochrome C, and 50 mM phosphate buffer, pH
7.2, Sigma). Reaction was followed as the increase in
reduced Cytochrome C absorbance at 550 nm (OD
18500 M
-1.cm
-1) after the addition of 35 μM of freshly
prepared ubiquinol 2. Complex IV (Cytochrome C oxi-
dase) activity and Complex II+III (succinate-Cyto-
chrome C reductase) activities were previously described
[18]. Levels of Cytochrome C were measured by western
blot using a commercial antibody (Cell signalling Tech-
nology, Danvers, MA, USA).
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and mPTP opening
Mitochondrial ΔΨ was measured with the non-quench-
ing Tetramethylrhodamine, methyl ester (TMRM) fluor-
escence methods (Molecular Probes, Life Technologies).
MEFs were stained with TMRM (50 nM) in DMEM for
30 min at 37°C in the dark. The cells were then washed
twice with PBS. Mitochondrial PTP opening was assessed
by the quenching of calcein-AM fluorescence by cobalt
[24]. Thirty min after cells were loaded with Calcein-AM
(1 μM, Molecular Probes, Life Technologies) at 37°C in
the dark, CoCl2 (1 mM, Sigma) was added and cells incu-
bated for another 10 min. Then, fluorescence of 30,000
cells for each experiment was measured with a flow cyt-
ometer (FACSCalibur), and the data were processed with
the CellQuest program (BD Biosciences, San Jose, CA,
USA). Neurons were incubated for 30 min with TMRM
(50 nM) in neuronal extracellular buffer with calcium or
with Calcein (1 μM) for 45 min in the dark after 30 min
CoCl2 (1 mM) was added. Then cells were washed and
imaged on a Leica DMI6000 Microscope. Imaging pro-
cessing and data analysis were performed using LASAF
software (Leica, Wetzlar, Germany). In some experiments
cells were pre-incubated for 1 hr with atractylate (20 μM,
Sigma), Cyclosporine A (CsA, 1 μM, Sigma), Bongkrekic
acid (BkA, 10 μM, Sigma), FK-506 (5 μM, Sigma), 0.1%
vehicle (DMSO), Tocopherol (50 μM, 4 hr, Sigma) or
NAC (1 mM, 2 hr, Sigma).
For imaging expreriments, MEFs were cultured on
glass bottom culture dishes. Cells were loaded for Δψm
with TMRM (50 nM) and Mitotracker Green (200 nM)
(Molecular Probes, Life Technologies) with or without
Oligomycin (1 μM), FCCP (1 μM) or CoCl2 (1 mM). For
the mPTP opening assay, cells were loaded with calcein-
AM (1 μM) and Mitotracker Red (150 nM) (Molecular
Probes, Life Technologies), with or without CoCl2
(1 mM) both in HBSS 1X (Gibco, Life Technologies) for
20 min at 37°C. Then, cells were washed three times in
HBSS 1X. Live images of the cells were captured with
the Olympus FluoView FV1000 Confocal Microscope
(Olympus Imaging America Inc, Center Valley, PA,
USA) and analyzed using ImageJ software.
Oxidative stress assay
To measure H2O2 production mitochondria were iso-
lated using the mitochondrial isolation kit from Sigma
according to the manufacturer instructions. The experi-
ment was started by adding 100 μl of assay buffer (HBSS
containing 10 μM Amplex Red, 10 mM succinate, 0.2
units/ml Horse Radish Peroxidase) and followed over
time on a fluorescence plate reader. The same condi-
tions were used to determine the production of super-
oxide anion using the Dihydroethidium (10 μM, DHEt)
method. The protein carbonyl contents in cell lysates
were detected by the OxyBlot protein oxidation detec-
tion kit (Millipore, Billerica, MA) using the instructions
provided by the manufacturer. Lipid peroxidation was
analyzed using the ThioBarbituric Acid Reactive Species
(TBARS) assay and according to the manufacturer's
instructions (Cayman Chemical, Ann Arbor, MI, USA).
Analysis of mitochondrial morphology
For visualization of mitochondria, MEFs were either
stained with Mitotracker Red (250 nM) or infected with
a retrovirus expressing mt-DsRed [25]. Primary cultured
neurons were only imaged with MitoTracker Red (100
nM). Then cells were washed for 10 min and fixed with
4% PFA (Electron Microscopy Science, Hatfield, PA,
USA) for 20 min. After fixation coverslips were mounted
on glass slides and imaged by epifluorescence on a Leica
DMI6000 Microscope (Leica Microsystems GmbH, Wet-
zlar, Germany). For live imaging, after staining cells were
mounted on a perfusion chamber in culture media con-
taining HEPES (1 mM) and imaged at 22°C. Regardless
of the staining method, cells were then scored by eye
into four different categories according to the morph-
ology of their mitochondrial network previously
described [25]. The automatic analysis of the size and
branching of the mitochondrial network was done using
the particle analysis function of ImageJ according to a
previously described methods using ImageJ [26].
Calcium imaging
FCCP releasable pool was measured by adapting a previ-
ously described method [27]. Briefly, MEFs and primary
cortical neurons cultures were loaded with Fura-2 AM
(5 μM, 45 min at 37°C) (Molecular probes, Life Tech-
nologies), and imaged with a Leica DMI6000 Micro-
scope. Imaging processing and data analysis were
performed using LAS AF software (Leica). FCCP (1 μM)
was applied using an 8-channel gravity perfusion system
(ALA Scientific Instrument, Farmingdale, NY, USA).
Statistical analysis
Statistical analysis was performed using Prism 5 (Graph-
Pad Software) and Excel (Microsoft). Pooled results were
expressed as means±SEM. Significance was determined
by the non paired Student t-test.
Results
Respiratory defects in intact mitochondria but normal
activities of enzymes in the mitochondrial electron
transport system (ETS) in PINK1-deficient cells
Our previous study revealed that respiratory activity is
impaired in mitochondria isolated from striata or aged
cortices of PINK1−/− mice [18]. To investigate further
the underlying mechanisms, we derived mouse embry-
onic fibroblasts (MEFs) from PINK1−/− mice. MEFs
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intact cellular environment and are more amenable to
experimental manipulations than mitochondria isolated
from brains. We first examined whether intact mito-
chondria in PINK1−/− MEFs recapitulate the mitochon-
drial defects observed in isolated mitochondria from
PINK1−/− striata. We measured the endogenous respira-
tory activity of primary MEFs energized with glucose
(10 mM). Consistent with our earlier in vivo findings,
endogenous respiration rate is reduced in PINK1−/−
fibroblasts (Figure 1A and 1B).
Respiratory defects in PINK1-deficient cells have been
suggested to result from impaired plasma membrane
glucose transporter activity, which reduces substrates de-
livery to mitochondria [15]. To bypass the glucose trans-
porter, we measured the respiratory activity of digitonin-
permeabilized cells energized with 10 mM glutamate/
malate (complex I substrate) or 10 mM succinate (com-
plex II substrate) or 1 mM Ascorbate/1 mM TMPD
(complex IV substrates) in the presence of saturating
concentrations of ADP (1 mM). The use of digitonin
(0.01% final concentration) allows the direct delivery of
substrates to mitochondria by specifically permeabilizing
the plasma membrane without affecting mitochondrial
integrity. Interestingly, we found that state 3 activities,
which represent the maximum respiration rate in the
presence of ADP are significantly decreased for complex
I and complex II substrates in PINK1−/− fibroblasts
(Figure 1C and 1D). These results are similar to what we
and others have independently reported in PINK1−/−
mice and MEFs [16,18], indicating that PINK1−/− MEFs
represent a valid cellular model to study the detailed
mechanisms underlying respiratory defects seen in
PINK1−/− mice.
Oxidative phosphorylation is a complex process rely-
ing on the proper function of several enzymatic com-
plexes and the maintenance of transmembrane potential
(ΔΨm). We therefore measured the enzymatic activities
of all individual complexes composing the electron
transport system (ETS) in MEFs. Using spectrophoto-
metric methods, we measured enzymatic activities for
complex I (NADH-ubiquinone reductase activity), com-
plex II (succinate-ubiquinone reductase activity), com-
plex III (ubiquinol-Cytochrome C reductase activity) and
complex IV activity (Cytochrome oxidase activity). After
normalization to citrate synthase activity, enzymatic ac-
tivities of all complexes composing the ETS appear nor-
mal in PINK1−/− MEFs (Figure 1E). Reduced respiration
has been documented to result from coenzyme Q defi-
ciency, which affects the transfer of electrons from
Figure 1 Impaired mitochondrial respiration in PINK1−/− fibroblasts. A. Representative oxygraphs of PINK1−/− (−/−) and wild-type (+/+)
MEFs energized with glucose (10 mM). The arrow indicates the time MEFs are added to the chamber. B. Bars show oxygen consumption, which
represents the endogenous respiratory activity in PINK1−/− and +/+ MEFs. C Representative oxygraphs of PINK1−/− and +/+ MEFs energized with
10 mM glutamate/malate (complex I substrate), 10 mM succinate (complex II substrate) or 1 mM TMPD/1 mM ascorbate (complex IV substrate) in
the presence of ADP (1 mM). Arrows indicate the time of the addition of either the substrates or oligomycin (2 μM). D. Bars show State 3
respiratory activity for complex I, II and IV in PINK1−/− and +/+ MEFs permeabilized with digitonin. E. Enzymatic activities of complexes I, II, III and
IV of the mitochondrial electron transport system, as measured by spectrophotometric assays and after normalization to citrate synthase activity.
F. Graph represents succinate-cytochrome C oxidase (complex II+III) activity. G. Upper panel: Representative western blot showing levels of
cytochrome C in the mitochondrial fraction of PINK1−/− and +/+ MEFs. Hsp75 is used as a control for the total amount of mitochondrial proteins
loaded in each well. Lower panel: The bar graph shows relative quantification of the level of Cytochrome C using Hsp75 as loading control. All
data are expressed as mean±SEM. * p<0.05, ** p<0.01.
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coenzyme Q deficiency by measuring the antimycin sen-
sitive succinate-Cytochrome C reductase activity. This
activity was also found normal in PINK1−/− MEFs (Fig-
ure 1F). Reduced Cytochrome C in the intermembrane
space results in reduced electron transfer between com-
plex III and IV and impairs mitochondrial respiratory ac-
tivities. We measured the level of Cytochrome C in the
mitochondrial fraction of PINK1−/− MEFs and control
cells and found that the levels were similar between the
two genotypic groups after normalization using Hsp75
as loading control (Figure 1G).
Reduced mitochondrial transmembrane potential of
PINK1−/− MEFs
In the absence of enzymatic defects of the ETS com-
plexes, we turned our attention towards mitochondrial
transmembrane potential (ΔΨm), the electrochemical
force that modulates the kinetics of proton reentry to
the matrix through ATP-synthase. Using microscopic
and flow cytometric analyses, we measured the trans-
membrane potential of MEFs stained with TMRM (50
nM). TMRM is a cationic fluorescent dye that accumu-
lates inside the mitochondrial matrix according to the
membrane potential. Interestingly, TMRM fluorescence
signal is reduced in both experiments in PINK1−/−
MEFs (Figure 2A-D). To ensure that dye is equally
loaded and that the TMRM signal is not auto-quenched
we compared TMRM fluorescence in PINK1−/− and
control MEFs following oligomycin and FCCP treatment.
Oligomycin, an inhibitor of ATP synthase, induces
hyperpolarization of mitochondria and increases of
TMRM fluorescence, whereas FCCP dissipates trans-
membrane potential. No differences in TMRM fluores-
cence between the two genotypes were found following
either of these treatments.
We investigated whether ΔΨm is similarly affected by
the loss of PINK1 in primary cortical neurons. Because
flow cytometry requires re-suspension of cells that could
damage mature neurons, we measured ΔΨm using fluor-
escence microscopy. Neuronal cultures were stained
with TMRM (50nM), imaged with a fluorescent micro-
scope and the intensity of the TMRM fluorescence was
determined for each individual neuron. Consistent with
what we have observed in fibroblasts, TMRM fluores-
cence is reduced by 40% in PINK1−/− neurons, confirm-
ing a reduction of ΔΨm in the absence of PINK1
(Figure 2E).
Increased mPTP opening in the absence of PINK1
Since the enzymatic activity of each component of the
ETS is normal, we looked for alternative mechanisms
underlying the reduction of ΔΨm. We evaluated opening
of the mitochondrial permeability transition pore, which
allows the diffusion of small ions across the mitochon-
drial inner membrane [29]. We compared opening of
mPTP in PINK1−/− and control MEFs under basal con-
ditions using the CoCl2-calcein fluorescence-quenching
assay [30]. Calcein-AM is a membrane permeable fluor-
ophore that diffuses freely into all subcellular compart-
ments including mitochondria. The acetoxymethyl (AM)
group of the fluorophore is cleaved by ubiquitous intra-
cellular esterase. Calcein, which is hydrophilic, is then
trapped within all subcellular compartments. The cells
are then loaded with the divalent cobalt cation (Co
2+),
which quenches calcein fluorescence in all subcellular
compartments except the mitochondrial matrix, as the
inner mitochondrial membrane is the only intracellular
membrane that is normally Co
2+-impermeable [30,31].
However, during the opening of the mPTP, cobalt enters
mitochondria and is able to quench mitochondrial cal-
cein fluorescence [32].
Under basal conditions, calcein fluorescence measured
by both microscopic and flow cytometric analyses is
lower in PINK1−/− MEFs, suggesting increases in mPTP
opening (Figure 3A-D). We also measured calcein fluor-
escence in the absence of cobalt. As expected, calcein
fluorescence is much higher in the absence of Co
2+ and
is similar between PINK1−/− and control cells, indicat-
ing similar calcein loading (Figure 3A-D). We extended
the analysis to PINK1−/− neurons to confirm if mPTP
opening is also increased. Because flow cytometric ana-
lysis requires re-suspension of cultured cells and thus
would damage mature neurons, we used only micro-
scopic analysis [33]. We found marked reduction of cal-
cein fluorescence in PINK1−/− cortical neurons, further
confirming increases in mPTP opening in the absence of
PINK1 (Figure 3E).
We further tested whether treatment of atractylate, an
agonist of the mPTP, would result in decreases of calcein
fluorescence. Following the treatment, calcein signal is
considerably reduced and the low level of calcein fluores-
cence is similar between the two genotypic groups in
both MEFs and neurons (Figure 4A-D). These results
provide additional support that the lower calcein signal in
PINK1−/− cells is due to increased opening of the mPTP.
We further treated cells with two agents that can in-
hibit opening of the mPTP. Treatment with cyclosporin
A (CsA), an inhibitor of mPTP, eliminated the genotypic
difference in calcein fluorescence between PINK1−/−
and control MEFs and neurons (Figure 4). Although
CsA is a strong inhibitor of the mPTP [34], it has add-
itional molecular targets such as calcineurin [35]. We
therefore used another mPTP inhibitor, bongkrekic acid,
which inhibits the mitochondrial ATP-ADP translocase,
a component of the mPTP, and has no inhibitory effect
on calcineurin [36]. Treatment with bongkrekic acid also
abrogates the genotypic difference in MEFs and neurons
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a potent calcineurin inhibitor that has no direct effect
on the mPTP [37], showed that it has little effect on cal-
cein signals (Figure 4). Using fluorescence based enzym-
atic assay we confirmed that treatment with FK-506
(5 μM) results in an almost complete inhibition of calci-
neurin activity (data not shown). These results provide
further support that loss of PINK1 results in increased
opening of the mPTP.
Inhibition of the mPTP opening rescues the reduction of
mitochondrial transmembrane potential and impairment
of mitochondrial respiration in PINK1−/− cells
To investigate whether increased opening of mPTP
underlies the mitochondrial functional defects in PINK1
−/− cells, we treated cells with mPTP agonist,
atractylate, as a positive control of the effects of mPTP
opening on mitochondrial depolarization. Treatment
with atractyloside acid results in a 64% reduction of
TMRM fluorescence in wild-type control cells compared
to basal conditions, indicating a strong depolarization of
mitochondrial inner membrane (Figure 5A and 5B).
We then treated the cells with mPTP inhibitors to de-
termine whether inhibition of mPTP opening can rescue
the transmembrane potential deficits in PINK1−/− cells.
Indeed CsA treatment fully rescued the reduced TMRM
fluorescence in PINK1−/− MEFs (Figure 5). Bongkrekic
acid also partially rescued the reduced TMRM fluores-
cence in PINK1−/− MEFs (Figure 5). FK-506 treatment
had no effect on TMRM fluorescence (Figure 5). Fur-
thermore, cobalt treatment did not alter TMRM signals
in PINK1−/− and +/+ MEFs, indicating that cobalt does
Figure 2 Reduced mitochondrial transmembrane potential in PINK1−/− cells. A. Representative confocal microscopic images of PINK1−/−
and +/+ MEFs after staining with TMRM (50 nM, red) and Mitotracker Green (200 nM) in the presence or absence of oligomycin (Olig, 1 μM) or
FCCP (10 μM). The intensity of TMRM reflects the level of mitochondrial transmembrane potential, whereas the intensity of Mitotracker Green is
not affected by transmembrane potential. The bottom right inserts are the higher power views of the boxed areas in the same panel. The TMRM
signal is reduced in PINK1−/− cells, whereas the TMRM signal is increased and decreased similarly in both PINK1−/− and +/+ cells following
oligomycin and FCCP treatment, respectively. B. The bar graph shows quantification of TMRM signals in PINK1−/− and +/+ MEFs in the presence
or absence of oligomycin and FCCP using confocal images. The number shown in the panel indicates the number of cells used in the study. C.
Representative flow cytometry dot plots show the intensity of TMRM signals in PINK1−/− and +/+ MEFs following incubation with TMRM (50 nM)
in the presence or absence of oligomycin (1 μM) or FCCP (10 μM). D. The bar graph shows quantification of TMRM signals measured by FACS
analysis in PINK1−/− and +/+ MEFs. The number shown in the panel indicates the number of independent experiments performed. E. The bar
graph of TMRM fluorescent signals in PINK1−/− and +/+ neurons shows reduced TMRM signals in PINK1−/− neurons. The numbers shown
indicate the number of neurons used (left) and the number of independent experiments performed (right) in the study. All data are expressed as
mean±SEM. Scale bar: 10 μm. * p<0.05, ** p<0.01, *** p<0.001.
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perimental time frames (Figure 5). These results show
that inhibition of mPTP opening rescues the reduction
in mitochondrial transmembrane potential in the ab-
sence of PINK1, suggesting that increased opening of
the mPTP underlies reduction of ΔΨm.
We further tested whether inhibition of mPTP open-
ing reverses the mitochondrial respiration impairment in
PINK1−/− cells. Treatment with CsA reduced the geno-
typic difference between PINK1−/− and control cells to
the extent that endogenous respiratory activity is similar
(Figure 6A and 6B). Moreover, CsA treatment almost
fully rescued complex I driven respiration in PINK1−/−
cells (Figure 6C and 6D). Treatment with FK-506 was
not able to rescue the respiratory impairment in PINK1
−/− cells, indicating that the effect of CsA on respiration
was specific for its inhibitory effect on mPTP (Figure 6E
and 6F).
Normal levels of oxidative stress in PINK1−/− cells
Because mPTP opening can be affected by elevated oxi-
dative stress [29], we went further to examine whether
there is an accumulation of oxidative species in the
mitochondrial fraction of PINK1−/− and control MEFs.
We measured the levels of protein carbonyls, a marker
of protein oxidation. As measured by OxyBlot, the total
level of carbonyls is similar between the two genotypic
groups (Figure 7A). We then measured the accumula-
tion of another common marker of oxidative stress, thio-
barbituric acid reactive substances (TBARS), which
reflects lipid peroxidation, and found no significant dif-
ferences between the two genotypes (Figure 7B). We
further evaluated the production of oxidative species.
Using the Amplex Red dye fluorescence assay we evalu-
ated the propensity of cells to generate Reactive Oxygen
Species (ROS) by measuring the production of H2O2.
Because H2O2 extrusion across the plasma membrane
can be kinetically limiting we measured the rate of
H2O2 produced by isolated mitochondria from MEFs.
Mitochondria are the main source of ROS in the cells.
We found that isolated mitochondria from PINK1−/−
and WT cells energized with succinate (10 mM) pro-
duce H2O2 at similar rates (Figure 7C). We also moni-
tored the production of superoxide anion O2
.-
.
Superoxide is the primary oxidant species generated as
a byproduct of mitochondrial respiration. Using the
Figure 3 Increased opening of the mitochondrial permeability transition pore in PINK1−/− cells. A. Representative confocal microscopic
images of PINK1−/− and +/+ MEFs after incubation with calcein-AM (1 μM) and Mitotracker Deep Red (150 nM) in the presence or absence of
Co
2+ (1 mM), which quenches calcein fluorescence (green) outside of mitochondria. Mitotracker Deep Red allows visualization of calcein
fluorescence in mitochondria. The bottom right inserts are the higher power views of the boxed areas in the same panel. The calcein
fluorescence in mitochondria is lower in PINK1−/− cells in the presence of Co
2+. In the absence of Co
2+, calcein fluorescent signals are very
intense and are present in the entire cell, and there are no genotypic differences. B. The bar graph shows quantification of calcein fluorescence in
PINK1−/− and +/+ cells in the presence or absence of Co
2+ using confocal images. The number shown in the panel indicates the number of cells
used in the study. C. Representative flow cytometry dot plots show the intensity of calcein signals in PINK1−/− and +/+ MEFs following
incubation with calcein-AM (1 μM) in the presence or absence of Co
2+ (1 mM). D. The bar graph of calcein signals measured by FACS analysis
shows reduced calcein signals in PINK1−/− MEFs in the presence of Co
2+. The number shown in the panel indicates the number of independent
experiments performed. E. The bar graph of calcein fluorescent signals in PINK1−/− and +/+ neurons shows reduced calcein signals in PINK1−/−
neurons. The numbers shown indicate the number of neurons used (left) and the number of independent experiments performed (right) in the
study. All data are expressed as mean±SEM. Scale bar: 10 μm. * p<0.05, ** p<0.01.
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http://www.molecularneurodegeneration.com/content/7/1/22Figure 4 Effects of mPTP agonists and inhibitors on its opening in PINK1−/− cells. A. Representative flow cytometry dot plots showing
calcein fluorescence in PINK1−/− and +/+ cells treated with calcein-AM (1 μM) and Co
2+ (1 mM) under basal conditions or following various
treatment, such as in presence of the mPTP agonist atractylate (20 μM), the mPTP inhibitors Cyclosporine A (CsA, 1 μM) or Bongkrekic acid (BkA,
10 μM), or the calcineurin inhibitor FK-506 (5 μM). B. The bar graph shows quantification of calcein fluorescence after FACS analysis following
various treatment, such as atractylate (20 μM), CsA (1 μM), BkA (10 μM), or FK-506 (5 μM). The number shown in the panel indicates the number
of independent experiments performed. C. Representative images showing calcein fluorescence in PINK1−/− and +/+ cortical neurons incubated
with calcein-AM (1 μM) and Co
2+ (1 mM) under basal conditions or in the presence of atractylate (20 μM), CsA (1 μM), BkA (10 μM) or FK-506
(5 μM). D. Quantification of calcein fluorescence in PINK1−/− and +/+ neurons following various treatment with atractylate (20 μM), CsA (1 μM) or
BkA (10 μM) or FK-506 (5 μM). The numbers shown in panels indicate the number of cells used (left) and the number of independent
experiments performed (right) in the study. All data are expressed as mean±SEM. * p<0.05.
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of O2
.- generation between PINK1−/− and WT MEFs
(Figure 7D). As positive controls we used MEFs derived
from our DJ-1−/− mice. Using the same assay condi-
tions, DJ-1 MEFs displayed higher rates of H2O2 and
O2
.- production as monitored with the Amplex Red and
the DHEt assays (data not shown). Thus, loss of PINK1
does not increase the production of reactive oxygen
species.
We further evaluated the effect of antioxidant treat-
ments on mPTP opening. Cells were treated with Toc-
opherol and N-acetyl-Cysteine. Tocopherol is a cell
permeable antioxidant, which reduces lipid oxidative
stress and has been shown to prevent mPTP opening in
conditions of elevated oxidative stress [38]. N-Acetyl-
Cysteine is a cell permeable precursor of glutathione,
which can prevent oxidative stress induced mPTP [39].
Calcein fluorescence levels remained reduced in PINK1
−/− MEFs compared to control cells following antioxi-
dant treatment (Figure 7E and 7F). These results suggest
that increased mPTP opening in PINK1−/− MEFs un-
likely results from elevated oxidative stress.
Normal mitochondrial morphology in PINK1-deficient cells
Given the earlier reports on the effects of PINK1 inacti-
vation in mitochondrial fusion [9,40,41] and fission
[10,13,42] in fruit flies and mammalian cell lines, we
examined whether mitochondrial morphology is affected
in PINK1−/− MEFs and neurons, which could contribute
to the functional deficits we observed in these cells. We
assessed mitochondrial morphology in PINK1−/− and
wild-type MEFs using a previously established method
[25]. MEFs were transfected with the mitochondria tar-
geted fluorescent protein mt-dsRed then analyzed by
distributing cells into four different categories according
to the morphology of their mitochondrial network: (I)
cells with a tubular mitochondrial network and less than
5 small round mitochondria; (II) cells with more than
50% tubular mitochondria; (III) cells with more than
50% small and spherical mitochondria; (IV) cells with a
fragmented mitochondrial network and less than 5 tubu-
lar mitochondria. Under basal conditions, PINK1−/−
and WT MEFs show similar distribution among the four
categories (Figure 8A). To circumvent any possible arti-
facts due to overexpression of a mitochondrial protein,
we performed the same analysis using MitoTracker Red
on fixed cells and still did not observe any significant
differences between the two genotypic groups (Fig-
ure 8B). A similar study on primary cortical neurons
derived from PINK1−/− and WT mice also showed com-
parable tubularity of the mitochondrial network in both
genotypic groups (Figure 8C).
We next sought to assess mitochondrial morphology in
a more quantitative manner. We quantified the number
and the average size of mitochondria in each cell using
ImageJ on binary images (Figure 8D panels i and ii) of
MitoTracker Red stained cells as previously described
[26]. We did not observe significant differences between
genotypes in these two parameters (Figure 8E). We further
quantified the number of branches and junctions per
mitochondrion using mitochondrial skeleton images, and
did not observe any significant differences between the
Figure 5 Blockade of mPTP opening attenuates the defect in mitochondrial transmembrane potential in PINK1−/− MEFs. A.
Representative flow cytometry dot plots showing TMRM fluorescence in PINK1−/− and +/+ cells incubated with TMRM (50 nM) and atractylate
(20 μM), CsA (1 μM), BkA (10 μM), FK-506 (5 μM) or Co
2+ (1 mM). B. The bar graph shows mitochondrial membrane potential measured by TMRM
fluorescence after FACS analysis following various treatment, atractylate (20 μM), CsA (1 μM), BkA (10 μM), FK-506 (5 μM) or Co
2+ (1 mM). The
number shown in the panel indicates the number of independent experiments performed. All data are expressed as mean±SEM. * p<0.05.
Gautier et al. Molecular Neurodegeneration 2012, 7:22 Page 9 of 15
http://www.molecularneurodegeneration.com/content/7/1/22genotypes (Figure 8E). Thus, loss of PINK1 does not affect
mitochondrial morphology in primary cultured MEFs and
neurons, at least under our culture conditions. These
results suggest that the functional deficits observed in
PINK1−/− MEFs and neurons are unlikely due to altered
mitochondrial morphology.
Increased mitochondrial calcium concentrations in PINK1-
deficient cells
We also evaluated mitochondrial calcium in the absence
of PINK1, since elevated mitochondrial calcium levels are
known to induce the opening of the mPTP [43]. We mea-
sured the size of the mitochondrial calcium pool by quan-
tifying the amount of calcium released from mitochondria
to the cytosol following FCCP treatment (1 μM). FCCP is
a specific proton ionophore that dissipates proton gradi-
ents and allows cations to freely redistribute across mem-
branes according to their concentration gradients.
Following FCCP treatment, alterations of cytosolic cal-
cium concentrations were monitored with Fura-2, a
BAPTA based dye whose fluorescence excitation ratio at
340 nm and 387 nm are proportional to cytosolic calcium
concentrations. Increases in Fura-2 signals following
FCCP treatment are much higher in PINK1−/− MEFs
(Figure 9A and 9B) and neurons (Figure 9C and 9D)
compared to their respective wild-type controls. These
results suggest loss of PINK1 results in selective increase
in mitochondrial calcium.
Discussion
In the current study, we investigated the mechanism
underlying the mitochondrial respiration defects caused
by loss of PINK1. We established primary MEFs and
cortical neuronal cultures from our PINK1−/− mice to
evaluate mitochondrial functions in intact cells. Similar
to what we previously reported in mitochondria isolated
from mouse brains [18], mitochondrial respiration is
impaired in PINK1−/− MEFs, indicating that these cells
represent a valid cellular model to study the detailed
mechanisms underlying respiratory defects seen in
PINK1−/− mice (Figure 1). Although respiration impair-
ment can be caused by defects in mitochondrial trans-
membrane potential or the electron transport system,
we found that only the mitochondrial transmembrane
potential is reduced in PINK1−/− cells (Figure 2), while
enzymatic activities of the complexes composing the
electron transfer system are unaffected (Figure 1). In
search for mechanisms underlying the reduction of the
transmembrane potential, we found that opening of the
mitochondrial permeability transition pore is increased
Figure 6 Blockade of mPTP opening by CsA attenuates the respiratory defect in PINK1−/− MEFs. A. Representative oxygraphs of PINK1−/−
and +/+ MEFs energized with glucose (10 mM) in the presence of CsA (1 μM). The arrows indicate the time MEFs are added to the chamber. B.
Oxygen consumption, which represents the endogenous respiratory activity in PINK1−/− and +/+ MEFs after treatment with CsA (1 μM). C.
Representative oxygraphs of PINK1−/− and +/+ MEFs energized with 10 mM glutamate/malate (complex I substrate), 10 mM succinate (complex
II substrate) or 1 mM TMPD/1 mM ascorbate (complex IV substrate) in the presence of CsA (1 μM). Arrows indicate the time of the addition of
either the substrate or oligomycin (2 μM). D. Graph showing State 3 respiratory activity for complex I, complex II and complex IV in PINK1−/− and
+/+ MEFs permeabilized with digitonin after treatment with CsA (1 μM). E. Representative oxygraphs of PINK1−/− and +/+ MEFs energized with
10 mM glutamate/malate (complex I substrate), 10 mM succinate (complex II substrate) or 1 mM TMPD/1 mM ascorbate (complex IV substrate)
after treatment with FK-506 (5 μM). Arrows indicate the time of the addition of either the substrate or oligomycin (2 μM). F. Graph showing State
3 respiratory activity for complex I, complex II and complex IV in PINK1−/− and +/+ MEFs permeabilized with digitonin after treatment with FK-
506 (5 μM). All data are expressed as mean±SEM. * p<0.05.
Gautier et al. Molecular Neurodegeneration 2012, 7:22 Page 10 of 15
http://www.molecularneurodegeneration.com/content/7/1/22in the absence of PINK1 and that this defect can be res-
cued by inhibitors of the mPTP (Figures 3 and 4). Fur-
thermore, mitochondrial transmembrane potential and
respiration defects caused by loss of PINK1 were also
reversed specifically by inhibitors of the mPTP (Figures 5
and 6), suggesting that increased opening of the mPTP
underlies the defects in mitochondrial transmembrane
potential and respiration observed in PINK1−/− cells.
These mitochondrial functional defects occur in the ab-
sence of elevated oxidative stress (Figure 7) and mito-
chondrial morphological changes (Figure 8), but
mitochondrial calcium is increased in PINK1−/− cells,
suggesting that elevated mitochondrial calcium underlies
the increase in mPTP opening (Figure 9).
Following our initial report of mitochondrial respir-
ation defects in PINK1−/− mouse brains [18], a growing
consensus has been building on the importance of
PINK1 in mitochondrial respiration [15-19,44], though
the underlying mechanism remained unclear. Defects in
the activity of the electron transport system complexes
have been suggested as a possible mechanism underlying
the respiratory defects resulting from the loss of PINK1,
as silencing PINK1 expression by siRNA in SH-SY5Y
cells affected mitochondrial ATP synthesis and activity
of ETC complexes [19]. However, enzymatic activities of
the ETC complexes in our primary PINK1-deficient cells
are normal. Instead we found that loss of PINK1
increased opening of the mitochondrial permeability
transition pore, and that blocking mPTP opening
occluded the difference between PINK1−/− and control
MEFs for endogenous and State 3 respiration. These
results suggest that increased mPTP opening is respon-
sible for reduced mitochondrial respiration in PINK1−/−
cells. Previous reports showed that mPTP opening trig-
gered by elevated calcium concentrations leads to
reduced state 3 respiratory activities [45,46], an effect
that can be prevented by pretreatment with CsA
[45,47,48].
Reduced transmembrane potential in PINK1-deficient
cells has been reported in a wide variety of cells [15-
17,21,49]. In accordance with these previous reports, we
also found that ΔΨm is reduced in primary PINK1−/−
fibroblasts and neurons. It has been proposed that
reduced enzymatic capacity of complex I of the mito-
chondrial electron transport system might be the under-
lying cause of the defects in ΔΨm [11]. However, similar
to other previous studies [17,50,51], we found that com-
plex I enzymatic activity as well as the activity of all
other complexes composing the ETS are normal in our
cell models in the absence of PINK1. Rather, we found
Figure 7 Normal levels of oxidative stress markers and normal production of reactive oxygen species in PINK1−/− MEFs. A. Left panel:
OxyBlot analysis of mitochondrial fractions showing levels of protein carbonyls in both genotypes. Right panel: Quantification of levels of protein
carbonyls in PINK1−/− and +/+ MEFs. B. Levels of lipid peroxidation measured by the TBARS assay in PINK1−/− and +/+ MEFs. C. Kinetics of H2O2
production in isolated mitochondria measured by following Amplex Red fluorescence over time. D. Kinetics of cytosolic superoxide anion O2
-
production measured in resuspended MEFs by following DHEt fluorescence over time. E. Representative flow cytometry dot plots showing
calcein fluorescence in PINK1−/− and +/+ MEFs in the presence of Co
2+ after antioxidant treatment with Tocopherol (50 μM, 4 hr) or NAC (1 mM,
2 hr). F. Quantification of calcein fluorescence in PINK1−/− and +/+ MEFs following treatment with Tocopherol (50 μM, 4 hr) or NAC (1 mM, 2 hr).
All data are expressed as mean±SEM. *p<0.05.
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portant role in the mitochondrial depolarization
observed in PINK1−/− cells, as inhibitors of the mPTP,
CsA and BkA, rescued the ΔΨm defects in PINK1−/−
cells. The opening of the mPTP allows free diffusion of
small ions across the mitochondrial inner membrane as
a corrective mechanism for cation overload [52-54].
Hence, increased opening of the mPTP allows a partial
depolarization of the mitochondrial membrane, and this
defect can be reversed by inhibition of mPTP opening
such as CsA [24,52]. The stronger rescuing effect
observed with CsA might relate to the fact that, in
addition to blocking the mPTP, it also hampers mito-
chondrial calcium uptake, which may be increased in
PINK1-deficient cells, as suggested by higher mitochon-
drial calcium levels in these cells.
A possible role of PINK1 in modulating mitochondrial
morphology and dynamics emerged from studies in Dros-
ophila. Loss of PINK1 function in flies results in abnor-
mally large mitochondria with fragmented cristae and
reduced capacity to generate ATP [6,7]. This mitochon-
drial phenotype is suppressed by genetically promoting
mitochondrial fission or decreasing mitochondrial fusion,
inferring that perturbed mitochondrial fission in PINK1-
deficient models underlies functional defects [9,40,41].
However, whether and how PINK1 may regulate mito-
chondrial morphology and dynamics in mammalian cells
is much less clear. The effects of PINK1 deficiency on
mitochondrial morphology and dynamics seem to depend
on the cell type studied and range from inducing mito-
chondrial fission [10,42] or fusion [14] to no effect
[11,16,19,50]. Consistent with these studies [11,16,19,50],
our analysis of primary cultured PINK1−/− MEFs and
neurons did not show overt changes in mitochondrial
morphology in fixed or live cells (Figure 8). These findings
are also in agreement with our earlier EM study showing
that no drastic ultrastructural changes in mitochondrial
number and integrity in PINK1−/− brains at 3–4a n d2 2 –
24 months of age [18]. Thus, loss of PINK1 function
causes mitochondrial functional defects, in the absence of
morphological changes, suggesting that the morphological
abnormalities observed in mammalian cell lines may be
downstream consequences of these mitochondrial func-
tional defects.
How does loss of PINK1 lead to increased mPTP
opening? Opening of the mPTP is primarily induced by
oxidative stress and/or elevated intramitochondrial cal-
cium concentrations [45]. We did not find any evidence
of oxidative damage or increased production of ROS in
PINK1-deficient cells (Figure 7). However, we found that
mitochondrial calcium concentration measured indir-
ectly in the cytosol following FCCP treatment is
increased in PINK1−/− MEFs and neurons (Figure 9).
This observation is consistent with a recent study
Figure 8 Unaltered mitochondrial morphology in PINK1−/− MEFs and neurons. A. Distribution of live PINK1−/− and +/+ MEFs infected with
Mt-DsRed to the four morphological categories I, II, III and IV. B. Distribution of fixed PINK1−/− and +/+ MEFs stained with MitoTracker Red (250
nM) to the four morphological categories. C. Distribution of fixed PINK1−/− and +/+ cortical neurons stained with MitoTracker Red (100 nM) to
the four morphological categories. D. Representative fluorescent images of mitochondria stained with MitoTracker Red (250 nM) i) and the
resulting binary (ii) used for quantitative analysis. E. Quantitative analysis using ImageJ shows the size and the number of branches of
mitochondria in PINK1−/− and +/+ MEFs (P>0.05 for all parameters measured). All data are expressed as mean±SEM. The numbers shown
indicate the number of independent experiments performed in the study. For each experiment 100 cells were analyzed quantitatively.
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mitochondrial Na
+/Ca
2+ exchanger (NCX), which regu-
lates Na
+-dependent Ca
2+ efflux [15]. Pharmacologic in-
hibition of NCX activity leads to accumulation of
calcium in isolated mitochondria [55]. It is therefore
possible that impaired NCX activity in PINK1−/− cells
may lead to accumulation of mitochondrial calcium,
which in turn increases the opening of the mPTP. In this
context, the mPTP may serve as a Ca
2+-activated Ca
2+
release channel [56]. However, it is unclear how loss of
PINK1 affects the activity of the mitochondrial Na
+/Ca
2+
exchanger. A direct regulation of the mitochondrial Na
+/Ca
2+ exchanger by PINK1-mediated phosphorylation
is possible but difficult to demonstrate, since the mo-
lecular nature of the Na
+/Ca
2+ exchanger is unknown.
Mitochondrial dysfunction has long been thought to
play an important role in the pathogenesis of Parkinson’s
disease [57]. This is based on earlier studies using post-
mortem idiopathic PD brains showing mitochondrial
respiration impairment and oxidative damage [3], and
on findings that mitochondrial complex I inhibitors,
such as MPTP and rotenone, produce parkinsonian syn-
dromes in humans and experimental animal models
[4,5]. Our prior reports showing mitochondrial respir-
ation defects in Parkin−/− and PINK1−/− mouse brains
and linking these recessive PD genes to mitochondrial
function provided experimental evidence in support of a
causal role of mitochondrial functional impairment in
PD pathogenesis [18,58]. The current study highlights
the importance of mitochondrial permeability transition
pore opening in PINK1 mediated mitochondrial respir-
ation and function. Our recent unpublished work further
showed that loss of Parkin or DJ-1 also leads to increases
in mPTP opening (EG and JS, unpublished data). Thus,
increased mPTP may be a common mechanism leading
to PD pathogenesis.
In summary, our study highlights an important role of
PINK1 in the regulation of mitochondrial permeability
transition pore. Our findings suggest that dysregulation
of the opening of the mPTP likely underlies impairment
of mitochondrial respiration and reduction of mitochon-
drial transmembrane potential. Future studies will be
needed to elucidate the mechanism by which PINK1 reg-
ulates mitochondrial calcium homeostasis and opening
of the mPTP. Given the importance of mPTP opening in
the regulation of the release of proapoptotic factors from
mitochondria to the cytosol, it will be important to de-
termine whether alteration of mPTP opening is a key
mechanism underlying increased vulnerability of PINK1-
deficient cells to exogenous stressors [11,59]. In addition,
future studies are needed to determine whether
increased opening of the mPTP is a feature common to
other genetic forms of the disease, and whether modula-
tion of its opening may provide a novel therapeutic strat-
egy for the treatment of Parkinson’s disease.
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